ARWR

Arrowhead Pharmaceuticals, Inc. - Common Stock (ARWR)

About Arrowhead Pharmaceuticals, Inc. - Common Stock (ARWR)

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Details

Daily high

$61.73

Daily low

$57.24

Price at open

$61.65

52 Week High

$95.49

52 Week Low

$37.06

Market cap

8.7B

Dividend yield

Volume

1.8M

Avg. volume

1.7M

P/E ratio

-27.48

Arrowhead Pharmaceuticals, Inc. - Common Stock News